Clinical Trial Update: Antineoplaston Therapy in Treating Patients With Mantle Cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial of antineoplaston therapy for mantle cell lymphoma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mantle Cell Lymphoma

Drugs mentioned

• Antineoplaston therapy

Snippet

Sponsor: Burzynski Research Institute | Conditions: Contiguous Stage II Mantle Cell Lymphoma, Noncontiguous Stage II Mantle Cell Lymphoma | Phase 2 | Status: WITHDRAWN